Sangamo Therapeutics Inc (NASDAQ:SGMO) traded at $1.74 at close of the session on Monday, November 04 and made a downward move of -7.45% on its previous day’s price.
Looking at the stock we see that its previous close was $1.88 and the beta (5Y monthly) reads 1.233 with the day’s price range being $1.74 – $2.0. In terms of its 52-week price range, SGMO has a high of $2.30 and a low of $0.29. The company’s stock has gained about 122.79% over that past 30 days.
Sangamo Therapeutics Inc has a market cap of $400.66 million and is expected to release its quarterly earnings report in December. Estimates by analysts give the company expected earnings per share (EPS) of -0.03, with the EPS growth for the year raised at -0.49 for current year and -0.49 for next year.
The median projection represents growth squeezing down to 72.50% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for current year is expected to hit 54.3M, or -69.20% down from figures reported last year.
On the other hand, looking at the outlook for the SGMO stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 100% Buy.
Based on estimates by 3 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 2 have rated the Sangamo Therapeutics Inc (SGMO) stock as a Hold, while 1 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Hold and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 33.80% off its SMA20 and 70.29% from its 50-day simple moving average. The RSI (14) is pointing at 64.44 while the volatility over the past week is 15.32% and jumps to 16.26% over the past one month. The beta value is 1.07, while the average true range (ATR) is currently pointing at 0.23. The average price target for the stock over the next 12 months is $12, with the estimates having a low of $5 and a high of $19. These price ends are -187.36% and -991.95% off the current price level respectively, although investors could be excited at the prospect of a -589.66% if the SGMO share price touches on the median price of $12.
Coming back to Sangamo Therapeutics Inc (NASDAQ:SGMO), we note that the average 3-month trading volume was 8.92 million, while that of the preceding 10-day period stands at 20.9 million. Current shares outstanding are 208.22 million.
The insiders hold 4.60% of the company’s shares while institutions hold 41.96%. The data shows that short shares as of 2024-10-15, stood at 18.22 million at a short ratio of 7.21. This represents a 880.00 short interest in shares outstanding on 2024-10-15. Shares short rose in October from the previous month at 17.5 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 220.27% up in year-to-date price movement.
